R Daniel Beauchamp Selected Research

R Daniel Beauchamp Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 06/2002
18	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2002
11	Carcinogenesis 11/2022 - 05/2002
10	Carcinoma (Carcinomatosis) 01/2018 - 06/2002
10	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2003
10	Colonic Neoplasms (Colon Cancer) 01/2016 - 08/2003
6	Adenoma (Adenomas) 01/2013 - 07/2004
3	Breast Neoplasms (Breast Cancer) 03/2006 - 07/2003
2	Colitis 11/2022 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 11/2022 - 11/2006
2	Esophageal Neoplasms (Esophageal Cancer) 02/2007 - 04/2005
2	Wounds and Injuries (Trauma) 06/2005 - 06/2002
1	Ulcerative Colitis 11/2022
1	Colitis-Associated Neoplasms 11/2022
1	Neuroblastoma 10/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2017
1	Adenocarcinoma 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014
1	Colonic Polyps 01/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2012
1	Polyps 11/2006
1	Crohn Disease (Crohn's Disease) 11/2006
1	Adenomatous Polyps 11/2006
1	Adenocarcinoma of Lung 06/2006
1	Pathologic Complete Response 03/2006
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2005
1	Lacerations 06/2005
1	Embolism (Embolus) 06/2005
1	Foreign Bodies (Foreign Body) 06/2005

Drug/Important Bio-Agent (IBA)

10	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 08/2002
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2003
8	Messenger RNA (mRNA)IBA 11/2022 - 07/2003
6	Cadherins (E-Cadherin)IBA 01/2017 - 11/2003
6	Biomarkers (Surrogate Marker)IBA 01/2016 - 03/2006
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2006 - 05/2002
3	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2003
3	Claudin-1IBA 12/2011 - 07/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2008 - 06/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 07/2003
3	ProstaglandinsIBA 11/2006 - 07/2002
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2006 - 05/2003
2	LigandsIBA 11/2022 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 07/2006
2	Smad4 ProteinIBA 01/2018 - 02/2007
2	Dextrans (Dextran)FDA Link 01/2018 - 01/2013
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2018 - 01/2013
2	IsoxazolesIBA 11/2017 - 10/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 05/2005
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 12/2014
2	Tight Junction ProteinsIBA 12/2011 - 02/2007
2	AgarIBA 02/2011 - 08/2004
2	EnzymesIBA 11/2006 - 08/2003
1	Chemokine ReceptorsIBA 11/2022
1	ChemokinesIBA 11/2022
1	CC ChemokinesIBA 11/2022
1	Drinking WaterIBA 01/2018
1	trametinibIBA 01/2017
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2017
1	VimentinIBA 01/2017
1	ParaffinIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2015
1	Extracellular Matrix ProteinsIBA 04/2014
1	CollagenIBA 04/2014
1	PeriostinIBA 04/2014
1	AzoxymethaneIBA 01/2013
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 03/2012
1	CateninsIBA 03/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2012
1	OligonucleotidesIBA 03/2012
1	Co-Repressor ProteinsIBA 01/2012
1	IntegrinsIBA 02/2011
1	Plasminogen Activator Inhibitor 1IBA 07/2008
1	Peptides (Polypeptides)IBA 07/2007
1	CytokinesIBA 02/2007
1	beta CateninIBA 02/2007
1	TCF Transcription FactorsIBA 02/2007
1	Peptide Hydrolases (Proteases)FDA Link 11/2006
1	Matrix Metalloproteinases (MMPs)IBA 11/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2006
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2006
1	Celecoxib (Celebrex)FDA Link 11/2006
1	Dinoprostone (PGE2)FDA Link 11/2006
1	Calcibiotic Root Canal SealerIBA 11/2006
1	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 11/2006
1	NF-kappa B (NF-kB)IBA 07/2006
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 07/2006
1	NF-KappaB Inhibitor alphaIBA 07/2006
1	Indicators and Reagents (Reagents)IBA 03/2006
1	ClaudinsIBA 07/2005

Therapy/Procedure

5	Therapeutics 01/2017 - 06/2002
3	Drug Therapy (Chemotherapy) 09/2012 - 07/2003
3	Lasers (Laser) 03/2012 - 07/2007
3	Radiotherapy 02/2007 - 07/2003
2	Aftercare (After-Treatment) 09/2012 - 11/2006
2	Adjuvant Chemotherapy 09/2012 - 03/2010
1	Immunomodulation 06/2019
1	TP protocol 02/2007
1	Chemoradiotherapy 02/2007